1721 related articles for article (PubMed ID: 29102619)
1. Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden.
Everhov ÅH; Halfvarson J; Myrelid P; Sachs MC; Nordenvall C; Söderling J; Ekbom A; Neovius M; Ludvigsson JF; Askling J; Olén O
Gastroenterology; 2018 Feb; 154(3):518-528.e15. PubMed ID: 29102619
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients.
Simian D; Fluxá D; Flores L; Lubascher J; Ibáñez P; Figueroa C; Kronberg U; Acuña R; Moreno M; Quera R
World J Gastroenterol; 2016 Jun; 22(22):5267-75. PubMed ID: 27298570
[TBL] [Abstract][Full Text] [Related]
3. Incidence, outcomes, and health services burden of very early onset inflammatory bowel disease.
Benchimol EI; Mack DR; Nguyen GC; Snapper SB; Li W; Mojaverian N; Quach P; Muise AM
Gastroenterology; 2014 Oct; 147(4):803-813.e7; quiz e14-5. PubMed ID: 24951840
[TBL] [Abstract][Full Text] [Related]
4. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
[TBL] [Abstract][Full Text] [Related]
5. Incidence, disease phenotype at diagnosis, and early disease course in inflammatory bowel diseases in Western Hungary, 2002-2006.
Lakatos L; Kiss LS; David G; Pandur T; Erdelyi Z; Mester G; Balogh M; Szipocs I; Molnar C; Komaromi E; Lakatos PL
Inflamm Bowel Dis; 2011 Dec; 17(12):2558-65. PubMed ID: 22072315
[TBL] [Abstract][Full Text] [Related]
6. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
7. Increased Mortality of Patients With Childhood-Onset Inflammatory Bowel Diseases, Compared With the General Population.
Olén O; Askling J; Sachs MC; Frumento P; Neovius M; Smedby KE; Ekbom A; Malmborg P; Ludvigsson JF
Gastroenterology; 2019 Feb; 156(3):614-622. PubMed ID: 30342031
[TBL] [Abstract][Full Text] [Related]
8. Pediatric inflammatory bowel disease: increasing incidence, decreasing surgery rate, and compromised nutritional status: A prospective population-based cohort study 2007-2009.
Jakobsen C; Paerregaard A; Munkholm P; Faerk J; Lange A; Andersen J; Jakobsen M; Kramer I; Czernia-Mazurkiewicz J; Wewer V
Inflamm Bowel Dis; 2011 Dec; 17(12):2541-50. PubMed ID: 21381152
[TBL] [Abstract][Full Text] [Related]
9. Incidence, Paris classification, and follow-up in a nationwide incident cohort of pediatric patients with inflammatory bowel disease.
Müller KE; Lakatos PL; Arató A; Kovács JB; Várkonyi Á; Szűcs D; Szakos E; Sólyom E; Kovács M; Polgár M; Nemes É; Guthy I; Tokodi I; Tóth G; Horváth Á; Tárnok A; Csoszánszki N; Balogh M; Vass N; Bódi P; Dezsőfi A; Gárdos L; Micskey E; Papp M; Cseh Á; Szabó D; Vörös P; Veres G;
J Pediatr Gastroenterol Nutr; 2013 Nov; 57(5):576-82. PubMed ID: 23820399
[TBL] [Abstract][Full Text] [Related]
10. Incidence and Clinical Outcomes of Inflammatory Bowel Disease in South Korea, 2011-2014: A Nationwide Population-Based Study.
Jung YS; Han M; Kim WH; Park S; Cheon JH
Dig Dis Sci; 2017 Aug; 62(8):2102-2112. PubMed ID: 28593437
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of paediatric inflammatory bowel disease in Sweden: a nationwide population-based register study.
Ludvigsson JF; Büsch K; Olén O; Askling J; Smedby KE; Ekbom A; Lindberg E; Neovius M
BMC Gastroenterol; 2017 Jan; 17(1):23. PubMed ID: 28143594
[TBL] [Abstract][Full Text] [Related]
12. Primary sclerosing cholangitis associated with inflammatory bowel disease: an observational study in a Southern Europe population focusing on new therapeutic options.
Franceschet I; Cazzagon N; Del Ross T; D'Incà R; Buja A; Floreani A
Eur J Gastroenterol Hepatol; 2016 May; 28(5):508-13. PubMed ID: 26872110
[TBL] [Abstract][Full Text] [Related]
13. Increased risk of atrial fibrillation and stroke during active stages of inflammatory bowel disease: a nationwide study.
Kristensen SL; Lindhardsen J; Ahlehoff O; Erichsen R; Lamberts M; Khalid U; Torp-Pedersen C; Nielsen OH; Gislason GH; Hansen PR
Europace; 2014 Apr; 16(4):477-84. PubMed ID: 24108228
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory bowel disease incidence in Czech children: A regional prospective study, 2000-2015.
Schwarz J; Sýkora J; Cvalínová D; Pomahačová R; Klečková J; Kryl M; Včelák P
World J Gastroenterol; 2017 Jun; 23(22):4090-4101. PubMed ID: 28652662
[TBL] [Abstract][Full Text] [Related]
15. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease.
Romberg-Camps MJ; Dagnelie PC; Kester AD; Hesselink-van de Kruijs MA; Cilissen M; Engels LG; Van Deursen C; Hameeteman WH; Wolters FL; Russel MG; Stockbrügger RW
Am J Gastroenterol; 2009 Feb; 104(2):371-83. PubMed ID: 19174787
[TBL] [Abstract][Full Text] [Related]
16. Health Care utilization in elderly onset inflammatory bowel disease: a population-based study.
Nguyen GC; Sheng L; Benchimol EI
Inflamm Bowel Dis; 2015 Apr; 21(4):777-82. PubMed ID: 25738376
[TBL] [Abstract][Full Text] [Related]
17. IBD in the elderly population: results from a population-based study in Western Hungary, 1977-2008.
Lakatos PL; David G; Pandur T; Erdelyi Z; Mester G; Balogh M; Szipocs I; Molnar C; Komaromi E; Kiss LS; Lakatos L
J Crohns Colitis; 2011 Feb; 5(1):5-13. PubMed ID: 21272797
[TBL] [Abstract][Full Text] [Related]
18. Regional differences in anti-TNF-α therapy and surgery in the treatment of inflammatory bowel disease patients: a Norwegian nationwide cohort study.
Lirhus SS; Høivik ML; Moum B; Melberg HO
Scand J Gastroenterol; 2018 Aug; 53(8):952-957. PubMed ID: 30205699
[TBL] [Abstract][Full Text] [Related]
19. A characterization in childhood inflammatory bowel disease, a new population-based inception cohort from South-Eastern Norway, 2005-07, showing increased incidence in Crohn's disease.
Perminow G; Brackmann S; Lyckander LG; Franke A; Borthne A; Rydning A; Aamodt G; Schreiber S; Vatn MH;
Scand J Gastroenterol; 2009; 44(4):446-56. PubMed ID: 19117240
[TBL] [Abstract][Full Text] [Related]
20. Infliximab Is Not Associated With Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric Patients With Inflammatory Bowel Disease.
Hyams JS; Dubinsky MC; Baldassano RN; Colletti RB; Cucchiara S; Escher J; Faubion W; Fell J; Gold BD; Griffiths A; Koletzko S; Kugathasan S; Markowitz J; Ruemmele FM; Veereman G; Winter H; Masel N; Shin CR; Tang KL; Thayu M
Gastroenterology; 2017 Jun; 152(8):1901-1914.e3. PubMed ID: 28193515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
